Immunovant Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $515.6M
Liabilities Breakdown FY2022
Total Liabilities: $45.7M
Asset Breakdown
Total Assets: $515.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $493.8M | 95.8% |
| Accounts Receivable | $12.2M | 2.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $330.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $9.2M | 1.8% |
Liabilities Breakdown
Total Liabilities: $45.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $18.6M | 40.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $27.1M | 59.3% |